Nevisense detects skin barrier damage in mice caused by household detergentsSeptember 1, 2022
STOCKHOLM, SWEDEN, - September 1, 2022 - SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders announced today scientific results that demonstrate the detrimental effects that common detergents can have on the health of the skin barrier. Top line results were presented recently at the World Immune Regulation Meeting (WIRM) in Davos, Switzerland. The study, which is not yet published, was performed by SIAF (CH), CK-CARE (CH), SciBase (SE) and the Sean N. Parker Allergy and Asthma research institute at Stanford (US). The study demonstrates that household laundry detergents disrupt the skin barrier integrity in mice.
FDA expert panel in line with SciBase position to keep stringent approval level for all new skin lesion analyzersAugust 9, 2022
STOCKHOLM, SWEDEN, - August 9, 2022 - SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that the FDA (US Food and Drug Administration) held a meeting with the Medical Devices Advisory Committee on July 28th and 29th to gather expert advice on the regulation of AI driven, skin lesion analyzers (SLAs) and Apps for skin cancer detection.
Annual general meeting has been held in SciBase Holding AB (publ) 2022May 18, 20222022-05-18 14:15 Today, the annual general meeting of 2022 was held in SciBase Holding AB (publ) (the “Company” or “SciBase”). Below follows a summary of the resolutions passed at the annual general meeting. The annual general meeting resolved: to adopt the profit and loss statement and the balance sheet and the group profit and loss […]
- Load more news...